Position in JNJ
as of Jun 30, 2026
· filed Jul 27, 2026
Position Value
$11,449,729
-$1,430,792 QoQ
Shares Held
45,083
-14.4% QoQ
Ownership
0.002%
of shares outstanding
% of Portfolio
2.73%
of 13F equity value
Holder Rank
#1,029
of 4,676 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in JNJ Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Blume Capital Management, Inc. holds $20,264,751 across 12 Drug Manufacturers - General names. JNJ ranks #1 (56.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
This page
|
45,083 | $11,449,729 | |
| 2 | PFE |
Pfizer Inc
|
241,130 | $5,806,410 | |
| 3 | SNY |
Sanofi
|
47,681 | $2,034,071 | |
| 4 | GILD |
Gilead Sciences, Inc.
|
3,160 | $399,234 | |
| 5 | AMGN |
Amgen Inc
|
530 | $191,923 | |
| 6 | MRK |
Merck & Co., Inc.
|
1,400 | $179,900 | |
| 7 | LLY |
ELI LILLY & Co
|
60 | $71,965 | |
| 8 | BMY |
Bristol Myers Squibb Co
|
1,054 | $60,731 |
All Filings in JNJ
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $11,449,729 | 45,083 | Shares | Sole | 2026-07-27 | |
| 2026-03-31 | $12,880,521 | 52,694 | Shares | Sole | 2026-05-01 | |
| 2025-12-31 | $13,794,873 | 66,658 | Shares | Sole | 2026-02-05 | |
| 2025-09-30 | $12,454,475 | 67,169 | Shares | Sole | 2025-11-06 | |
| 2025-06-30 | $10,278,853 | 67,292 | Shares | Sole | 2025-07-30 | |
| 2025-03-31 | $11,168,163 | 67,343 | Shares | Sole | 2025-05-06 | |
| 2024-12-31 | $9,806,392 | 67,808 | Shares | Sole | 2025-02-10 | |
| 2024-09-30 | $10,538,923 | 65,031 | Shares | Sole | 2024-10-29 | |
| 2024-06-30 | $9,523,639 | 65,159 | Shares | Sole | 2024-08-05 | |
| 2024-03-31 | $9,375,130 | 59,265 | Shares | Sole | 2024-05-02 | |
| 2023-12-31 | $9,054,086 | 57,765 | Shares | Sole | 2024-05-02 | |
| 2023-09-30 | $8,842,394 | 56,773 | Shares | Sole | 2024-05-02 | |
| 2023-06-30 | $9,519,220 | 57,511 | Shares | Sole | 2024-05-02 | |
| 2023-03-31 | $7,993,815 | 51,573 | Shares | Sole | 2024-05-02 | |
| 2022-12-31 | $7,786,732 | 44,080 | Shares | Sole | 2023-02-08 | |
| 2022-09-30 | $7,315,260 | 44,780 | Shares | Sole | 2022-11-15 | |
| 2022-06-30 | $7,991,855 | 45,022 | Shares | Sole | 2022-08-11 | |
| 2022-03-31 | $9,927,715 | 56,016 | Shares | Sole | 2022-05-12 | |
| 2021-12-31 | $9,668,534 | 56,518 | Shares | Sole | 2022-02-07 | |
| 2021-09-30 | $9,016,868 | 55,832 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $9,238,124 | 56,077 | Shares | Sole | 2021-08-10 | |
| 2021-03-31 | $8,866,682 | 53,950 | Shares | Sole | 2021-05-10 | |
| 2020-12-31 | $8,241,046 | 52,364 | Shares | Sole | 2021-02-09 | |
| 2020-09-30 | $7,914,014 | 53,157 | Shares | Sole | 2020-11-12 | |
| 2020-06-30 | $7,479,406 | 53,185 | Shares | Sole | 2020-08-06 | |
| 2020-03-31 | $7,110,393 | 54,224 | Shares | Sole | 2020-05-07 | |
| No filing history on record for this holder in this stock. | ||||||